Inventor
SAMPSON JOHN H
US22 patents
⚠️ This page may combine multiple inventors who share the name “SAMPSON JOHN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV DUKE
18 patentsUS10632190B2Apr 28, 2020
Compositions, methods and kits for eliciting an immune response
UNIV DUKE12 citations93
US9764026B2Sep 19, 2017
Compositions, methods, and kits for eliciting an immune response
UNIV DUKE19 citations92
US9011835B2Apr 21, 2015
Compositions, methods, and kits for eliciting an immune response
UNIV DUKE18 citations92
US6503503B1Jan 7, 2003
Allogeneic cellular vaccine
UNIV DUKE20 citations89
US11389530B2Jul 19, 2022
Compositions, methods and kits for eliciting an immune response
UNIV DUKE5 citations83
US11376322B2Jul 5, 2022
Compositions, methods and kits for eliciting an immune response
UNIV DUKE5 citations83
US11364295B2Jun 21, 2022
Compositions, methods and kits for eliciting an immune response
UNIV DUKE5 citations83
US11351248B2Jun 7, 2022
Compositions, methods and kits for eliciting an immune response
UNIV DUKE5 citations83
US10799543B2Oct 13, 2020
Oncolytic poliovirus for human tumors
UNIV DUKE4 citations82
US10398743B2Sep 3, 2019
Oncolytic poliovirus for human tumors
UNIV DUKE5 citations82
US9974848B2May 22, 2018
Tetanus toxoid and CCL3 improve DC vaccines
UNIV DUKE8 citations80
US9950056B2Apr 24, 2018
Compositions, methods and kits for eliciting an immune response
UNIV DUKE5 citations72
US11813298B2Nov 14, 2023
Oncolytic poliovirus for human tumors
UNIV DUKE1 citations71
US11406677B2Aug 9, 2022
Oncolytic poliovirus for human tumors
UNIV DUKE3 citations71
US12070496B2Aug 27, 2024
Compositions, methods and kits for eliciting an immune response
UNIV DUKE0 citations62
US11684662B2Jun 27, 2023
Tetanus toxoid and CCL3 improve DC vaccines
UNIV DUKE0 citations59
US11071777B2Jul 27, 2021
Tetanus toxoid and CCL3 improve DC vaccines
UNIV DUKE0 citations59
US10744171B2Aug 18, 2020
Sequential anti-cancer treatment
UNIV DUKE0 citations47